Three new structures of the core domain of HIV-1 integrase: An active site that binds magnesium

被引:310
|
作者
Goldgur, Y [1 ]
Dyda, F [1 ]
Hickman, AB [1 ]
Jenkins, TM [1 ]
Craigie, R [1 ]
Davies, DR [1 ]
机构
[1] NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1073/pnas.95.16.9150
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
HIV-1 integrase is an essential enzyme in the life cycle of the virus, responsible for catalyzing the insertion of the viral genome into the host cell chromosome; it provides an attractive target for antiviral drug design. The previously reported crystal structure of the HIV-1 integrase core domain revealed that this domain belongs to the superfamily of polynucleotidyltransferases. However, the position of the conserved catalytic carboxylic acids differed from those observed in other enzymes of the class, and attempts to crystallize in the presence of the cofactor, Mg2+, were unsuccessful. We report here three additional crystal structures of the core domain of HIV-1 integrase mutants, crystallized in the presence and absence of cacodylate, as well as complexed with Mg2+. These three crystal forms, containing between them seven independent core domain structures, demonstrate the unambiguous extension of the previously disordered helix alpha 4 toward the amino terminus from residue M154 and show that the catalytic E152 points in the general direction of the two catalytic aspartates, D64 and D116, In the vicinity of the active site, the structure of the protein in the absence of cacodylate exhibits significant deviations from the previously reported structures. These differences can be attributed to the modification of C65 and C130 by cacodylate, which was an essential component of the original crystallization mixture. We also demonstrate that in the absence of cacodylate this protein will bind to Mg2+, and could provide a satisfactory platform for binding of inhibitors.
引用
收藏
页码:9150 / 9154
页数:5
相关论文
共 50 条
  • [1] Solution Conformation and Dynamics of the HIV-1 Integrase Core Domain
    Fitzkee, Nicholas C.
    Masse, James E.
    Shen, Yang
    Davies, David R.
    Bax, Ad
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (23) : 18072 - 18084
  • [2] Minimal core domain of HIV-1 integrase for biological activity
    Kim, DJ
    Lee, SK
    Oh, YT
    Shin, CG
    MOLECULES AND CELLS, 2000, 10 (01) : 96 - 101
  • [3] THE CRYSTAL STRUCTURE OF THE CATALYTIC CORE DOMAIN OF HIV-1 INTEGRASE IN A NEW CRYSTAL FORM
    Dyda, Fred
    Hickman, Alison B.
    Jenkins, Timothy M.
    Engelman, Alan
    Craigie, Robert
    Davies, David R.
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 1996, 52 : C155 - C155
  • [4] Binding modes of HIV-1 integrase inhibitors at the active site
    Sotriffer, CA
    Ni, HH
    McCammon, JA
    RATIONAL APPROACHES TO DRUG DESIGN, 2001, : 83 - 87
  • [5] Active site binding modes of HIV-1 integrase inhibitors
    Sotriffer, CA
    Ni, HH
    McCammon, JA
    JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (22) : 4109 - 4117
  • [6] Active site binding modes of curcumin in HIV-1 protease and integrase
    Vajragupta, O
    Boonchoong, P
    Morris, GM
    Olson, AJ
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (14) : 3364 - 3368
  • [7] Design of inhibitors of the HIV-1 integrase core domain using virtual screening
    Regon, Preetom
    Gogoi, Dhrubajyoti
    Rai, Ashok Kumar
    Bordoloi, Manabjyoti
    Bezbaruah, Rajib Lochan
    BIOINFORMATION, 2014, 10 (02) : 76 - 80
  • [8] Catalytically-active complex of HIV-1 integrase with a viral DNA substrate binds anti-integrase drugs
    Alian, Akram
    Griner, Sarah L.
    Chiang, Vicki
    Tsiang, Manuel
    Jones, Gregg
    Birkus, Gabriel
    Geleziunas, Romas
    Leavitt, Andrew D.
    Stroud, Robert M.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (20) : 8192 - 8197
  • [9] The mobility of an HIV-1 integrase active site loop is correlated with catalytic activity
    Greenwald, J
    Le, V
    Butler, SL
    Bushman, FD
    Choe, S
    BIOCHEMISTRY, 1999, 38 (28) : 8892 - 8898
  • [10] Salicylhydrazine-containing inhibitors of HIV-1 integrase: Implication for a selective chelation in the integrase active site
    Neamati, N
    Hong, HX
    Owen, JM
    Sunder, S
    Winslow, HE
    Christensen, JL
    Zhao, H
    Burke, TR
    Milne, GWA
    Pommier, Y
    JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (17) : 3202 - 3209